Literature DB >> 3171551

Minute virus of mice non-structural protein NS-1 is necessary and sufficient for trans-activation of the viral P39 promoter.

C Doerig1, B Hirt, P Beard, J P Antonietti.   

Abstract

The genome of the autonomous parvovirus minute virus of mice (MVM) is organized in two overlapping transcription units: the genes coding for the two non-structural proteins (NS-1 ad NS-2) are transcribed from a promoter (P04) located at map unit 4, whereas the promoter controlling the capsid protein genes (P39) lies at map unit 39. We studied the effect of viral proteins on the activity of the P39 promoter in vivo. By site-directed mutagenesis we constructed clones encoding only one of the two NS proteins. The activity of the P39 promoter was measured in HeLa or EL-4 cells transfected with these clones, either by an RNase protection assay or by following the expression of a reporter gene, CAT (which codes for chloramphenicol acetyltransferase), placed under the control of this promoter. We found that the P39 promoter of strain MVMi is activated in trans by a viral gene product, and evidence to suggest that NS-1 is the only viral gene product responsible for this trans-activation. We also determined that the mechanism of trans-activation is very rapid, since all species of viral mRNAs appear together in non-synchronized infected EL-4 cells within a 2 h interval.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3171551     DOI: 10.1099/0022-1317-69-10-2563

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  51 in total

1.  Cloning and sequencing of defective particles derived from the autonomous parvovirus minute virus of mice for the construction of vectors with minimal cis-acting sequences.

Authors:  N Clément; B Avalosse; K El Bakkouri; T Velu; A Brandenburger
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

2.  The NS2 proteins of parvovirus minute virus of mice are required for efficient nuclear egress of progeny virions in mouse cells.

Authors:  Virginie Eichwald; Laurent Daeffler; Michèle Klein; Jean Rommelaere; Nathalie Salomé
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

Review 3.  Parvovirus replication.

Authors:  K I Berns
Journal:  Microbiol Rev       Date:  1990-09

4.  Parvovirus nonstructural proteins induce an epigenetic modification through histone acetylation in host genes and revert tumor malignancy to benignancy.

Authors:  Hiroyoshi Iseki; Rie Shimizukawa; Fumihiro Sugiyama; Satoshi Kunita; Atsushi Iwama; Masafumi Onodera; Hiromitsu Nakauchi; Ken-ichi Yagami
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

5.  Parvovirus NS1 stimulates P4 expression by interaction with the terminal repeats and through DNA amplification.

Authors:  N D Hanson; S L Rhode
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

6.  An in-frame deletion in the NS protein-coding sequence of parvovirus H-1PV efficiently stimulates export and infectivity of progeny virions.

Authors:  Nadine Weiss; Alexandra Stroh-Dege; Jean Rommelaere; Christiane Dinsart; Nathalie Salomé
Journal:  J Virol       Date:  2012-05-02       Impact factor: 5.103

Review 7.  DNA virus replication compartments.

Authors:  Melanie Schmid; Thomas Speiseder; Thomas Dobner; Ramon A Gonzalez
Journal:  J Virol       Date:  2013-11-20       Impact factor: 5.103

8.  Targeting of promoters for trans activation by a carboxy-terminal domain of the NS-1 protein of the parvovirus minute virus of mice.

Authors:  D Legendre; J Rommelaere
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

9.  The expression strategy of goose parvovirus exhibits features of both the Dependovirus and Parvovirus genera.

Authors:  Jianming Qiu; Fang Cheng; Yuko Yoto; Zoltán Zádori; David Pintel
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

10.  Severe leukopenia and dysregulated erythropoiesis in SCID mice persistently infected with the parvovirus minute virus of mice.

Authors:  J C Segovia; J M Gallego; J A Bueren; J M Almendral
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.